Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profile

This publication has 21 references indexed in Scilit:

• Doxorubicin interactions at the membrane: Evidence for a biphasic modulation of inositol lipid metabolism
  European Journal of Cancer and Clinical Oncology, 1991
• Hematopoietic Growth Factors
  New England Journal of Medicine, 1989
• Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy
  European Journal of Cancer and Clinical Oncology, 1989
• Pharmacokinetics of weekly low dose doxorubicin
  European Journal of Cancer and Clinical Oncology, 1989
• Flow Cytometric Analysis of Doxorubicin Accumulation in Cells From Human and Rodent Cell Lines
  JNCI Journal of the National Cancer Institute, 1989
• Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?
  Cancer Drug Delivery, 1987
• Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trial
  European Journal of Cancer and Clinical Oncology, 1986
• Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds
  The Journal of Clinical Pharmacology, 1986
• Optimal schedule for anthracyclines
  European Journal of Cancer and Clinical Oncology, 1985
• Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy
  Published by Elsevier ,1979